Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome

被引：73

作者：

Ajmani S.N. ^{[1
,2
]}

Aggarwal D. ^{[1
]}

Bhatia P. ^{[1
]}

Sharma M. ^{[3
]}

Sarabhai V. ^{[1
]}

Paul M. ^{[1
]}

机构：

[1] Department of Obstetrics and Gynecology, Kasturba Hospital

[2] P.O Tilak Nagar, New Delhi 110018, D-117, Ajay Enclave

[3] Department of Obstetrics and Gynecology, Hindu Rao Hospital, New Delhi

来源：

The Journal of Obstetrics and Gynecology of India | 2014年 / 64卷 / 2期

关键词：

Fetal outcome; Maternal outcome; Prevalence; Thyroid dysfunction;

D O I：

10.1007/s13224-013-0487-y

中图分类号：

学科分类号：

摘要：

Aim: To determine the current prevalence of thyroid dysfunction in normal pregnant women and to study the impact of thyroid dysfunction on maternal and fetal outcome. Methods: 400 pregnant women between 13 and 26 weeks of gestation were registered for the study. Apart from routine obstetrical investigations, TSH tests were done. Free T4 and anti-TPO antibody tests were done in patients with deranged TSH. Patients were followed up till delivery. Their obstetrical and perinatal outcomes were noted. Results: The prevalence of hypothyroidism and hyperthyroidism was 12 and 1.25%, respectively. Adverse maternal effects in overt hypothyroidism included preeclampsia (16.6 vs. 7.8%) and placental abruption (16.6 vs. 0.8%). Subclinical hypothyroidism was associated with preeclampsia (22.3 vs. 7.8%) as compared to the euthyroid patients. Adverse fetal outcomes in overt hypothyroidism included spontaneous abortion (16.6 vs. 2.39%), preterm birth (33.3 vs. 5.8%), low birth weight (50 vs. 12.11%), intrauterine growth retardation (25 vs. 4.9%), and fetal death (16.6 vs. 1.7%) as compared to the euthyroid women. Adverse fetal outcomes in subclinical hypothyroidism included spontaneous abortion (5.5 vs. 2.39%), preterm delivery (11.2 vs. 5.8%), low birth weight (25 vs. 12.11%), and intrauterine growth retardation (8.4 vs. 4.9%) as compared to the euthyroid women. Conclusions: The prevalence of thyroid disorders was high in our study with associated adverse maternal and fetal outcomes. Routine screening of thyroid dysfunction is recommended to prevent adverse fetal and maternal outcome. © Federation of Obstetric & Gynecological Societies of India 2013.

引用

页码：105 / 110

页数：5

共 13 条

[1]

Abalovich M., Amino N., Barbour L.A., Et al., Management of thyroid dysfunction during pregnancy and postpartum: An endocrine society clinical practice guideline, J Clin Endocrinol Metab, 92, 8, pp. 1-47, (2007)

[2]

Negro R., Formoso G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H., Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications, Journal of Clinical Endocrinology and Metabolism, 91, 7, pp. 2587-2591, (2006)

[3]

Sharma P.P., Mukhopadhyay P., Mukhopadhyay A., Et al., Hypothyroidism in pregnancy, J Obstet Gynecol India, 57, pp. 331-334, (2007)

[4]

Stagnaro-Green A., Overt hyperthyroidism and hypothyroidism during pregnancy, Clin Obstet Gynecol, 54, 3, pp. 478-487, (2011)

[5]

Hollowell J.G., Staehling N.W., Dana F.W., Harry H.W., Gunter E.W., Spencer C.A., Braverman L.E., Serum TSH, T<sub>4</sub>, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III), Journal of Clinical Endocrinology and Metabolism, 87, 2, pp. 489-499, (2002)

[6]

Glinoer D., Thyroid hyperfunction during pregnancy, Thyroid, 8, 9, pp. 859-864, (1998)

[7]

LeBeau S.O., Mandel S.J., Thyroid disorders during pregnancy, Endocrinology and Metabolism Clinics of North America, 35, 1, pp. 117-136, (2006)

[8]

Stagnaro-Green A., Abalovich M., Alexander E., Et al., Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy hypothyroidism in pregnancy and postpartum, Thyroid, 21, 10, pp. 1081-1125, (2011)

[9]

Clinical American management guidelines for obstetrician-gynecologists: Gestational diabetes: ACOG Practice Bulletin No. 30, Obstet Gynecol, 98, pp. 525-538, (2001)

[10]

Allan W.C., Haddow J.E., Palomaki G.E., Et al., Maternal thyroid deficiency and pregnancy complications: Implications for population screening, J Med Screen, 7, pp. 127-130, (2000)

← 1 2 →